84888-38-0 Usage
Description
CYSTEINE(FM)-OH, also known as L-cysteine, is a non-essential amino acid that is found in various protein-containing foods such as meat, eggs, and dairy products. It plays a crucial role in the synthesis of proteins and in the formation of the antioxidant glutathione.
Uses
Used in Dietary Supplements:
CYSTEINE(FM)-OH is used as a dietary supplement to support protein synthesis and the production of glutathione, which is an important antioxidant in the body.
Used in Food Industry:
CYSTEINE(FM)-OH is used as a precursor for the production of flavor enhancers such as monosodium glutamate (MSG) and as a stabilizer and flavoring agent in the food industry.
Used in Pharmaceutical Industry:
CYSTEINE(FM)-OH is used in the pharmaceutical industry as a precursor for the production of various drugs and as a stabilizer in formulations.
Used in Cosmetics:
CYSTEINE(FM)-OH is used in some cosmetic formulations for its antioxidant and hydrating properties, providing skin and hair benefits.
Check Digit Verification of cas no
The CAS Registry Mumber 84888-38-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,8,8 and 8 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 84888-38:
(7*8)+(6*4)+(5*8)+(4*8)+(3*8)+(2*3)+(1*8)=190
190 % 10 = 0
So 84888-38-0 is a valid CAS Registry Number.
84888-38-0Relevant articles and documents
Novel design of bicyclic β-turn dipeptides on solid-phase supports and synthesis of [3.3.0]-bicyclo[2,3]-leu-enkephalin analogues
Gu, Xuyuan,Ying, Jinfa,Agnes, Richard S.,Navratilova, Edita,Davis, Peg,Stahl, Gannon,Porreca, Frank,Yamamura, Henry I.,Hruby, Victor J.
, p. 3285 - 3288 (2007/10/03)
(Chemical Equation Presented) External bicyclic β-turn dipeptide mimetics provide an excellent design approach that can offer a rich chiral ensemble of structures with different backbone conformations. We report herein a novel design of a convergent combinatorial synthetic methodology, which is illustrated by the solid-phase synthesis of a series of [3.3.0]-bicyclo [2,3]-Leu-enkephalin analogues. The reactions were optimized and the epimeric configurations were determined by 2D NMR spectroscopy. Biological assays show that these analogues have more potent δ binding affinity and bioactivity for δ vs μ opioid receptor, which may be related to the different conformations preferred by these analogues in our modeling studies.